36 results on '"Morita, Midori"'
Search Results
2. Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer
3. Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from microarray data from fresh-frozen to FFPE tissues
4. Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer
5. Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316)
6. Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer
7. Is adjuvant chemotherapy necessary in older patients with breast cancer?
8. Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from microarray data from fresh-frozen to FFPE tissues
9. The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results
10. The Impact of Being Underweight on the Prognosis of Older Patients With Early Breast Cancer
11. Clarification attempt of the mechanism of late recurrence by micro- and macro-analyses in estrogen receptor-positive breast cancer
12. Seven‐plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi‐Institutional Collaborative Cohort Study.
13. Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
14. Abstract P5-02-05: Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative breast cancer in Japan
15. Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer
16. Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer
17. Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms
18. Contribuições de um projeto investigativo na formação de professores das séries iniciais
19. Oxidative stress induces EGFR inhibition-related skin cell death
20. The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results
21. Myoid hamartoma of the breast that proved difficult to diagnose: a case report
22. Fluorescence‐based discrimination of breast cancer cells by direct exposure to 5‐aminolevulinic acid
23. Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer
24. Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer
25. Vertically challenged: With repairs continuing, elevator issues inconvenience campus
26. Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2- primary breast cancer.
27. Research on the aspects of enjoyment of a park desired by university students through the evaluation experiment on their motivation for use and management participation
28. How escape-avoidance coping can be used to prevent stress responses
29. The Balance of Connective Tissue Growth Factor and Brain Natriuretic Peptide Regulates Myocardial Fibrosis and Stiffness
30. Cardiac sarcoidosis detected by FDG-PET.
31. [A Case of Aortitis Caused by Pegfilgrastim Use during Neoadjuvant Chemotherapy for Treating Breast Cancer].
32. [Experience of Fulvestrant for Hormone Receptor-Positive HER2-Negative Advanced and Metastatic Breast Cancer].
33. [Metastatic breast cancer with microangiopathic hemolytic anemia successfully treated by using eribulin].
34. [A case of effective lapatinib/capecitabine therapy for HER2-positive breast cancer with multiple brain metastases].
35. [Administration of nab-paclitaxel for 9 metastatic breast cancer patients].
36. [A case of effective combination therapy with docetaxel, cyclophosphamide and trastuzumab as primary systemic therapy for locally advanced HER2-positive breast cancer].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.